By www.marketscagr.com
Global Polycythemia Vera Treatment Market Research Report 2024 Story
116
$ 2900
Polycythemia Vera Treatment Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
ANP Technologies, INC.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Galena Biopharma, Inc.
Gilead Sciences, Inc
Italfarmaco S.P.A.
Karus Therapeutics Limited
Miragen Therapeutics, Inc
Zydus Cadila Incyte Corp.
Otsuka America Pharmaceutical, Inc. Pharmaclon
Teva Pharmaceuticals Inc.
Schering-Plough
GNC Vector
Alfarm
Merk and Co. Inc.
Pfizer.
Novartis AG
Bayer AG
Mylan N.V
GlaxosmithKline plc